Predictions
Athersys Inc.
Start price
Target price
Perf. (%)
€1.87
19.09.22
19.09.22
€3.80
19.09.23
19.09.23
0.19%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.64
19.09.22
19.09.22
€17.00
19.09.23
19.09.23
-34.41%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.41
27.09.22
27.09.22
€11.60
27.09.23
27.09.23
8.69%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€9.36
16.10.21
16.10.21
€20.00
16.10.22
16.10.22
47.44%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.08
18.05.22
18.05.22
-
18.05.23
18.05.23
-3.43%
16.10.22
16.10.22
Risky Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.86
08.10.22
08.10.22
€5.00
08.10.23
08.10.23
9.28%
16.10.22
16.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.12
04.09.22
04.09.22
-
04.09.23
04.09.23
-11.64%
15.10.22
15.10.22
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€6.61
29.08.22
29.08.22
-
29.08.23
29.08.23
-10.43%
15.10.22
15.10.22
Could be very worthwhile Investment >20% year
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.17
20.09.22
20.09.22
-
20.09.23
20.09.23
-15.38%
15.10.22
15.10.22
Risky Investment
Galapagos N.V.
Start price
Target price
Perf. (%)
€45.08
13.10.21
13.10.21
€46.00
13.10.22
13.10.22
-0.18%
14.10.22
14.10.22
Could be worthwhile Investment >10% per year
Galapagos N.V.
Start price
Target price
Perf. (%)
€45.08
13.10.21
13.10.21
€46.00
13.10.22
13.10.22
-0.18%
14.10.22
14.10.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.91
03.08.22
03.08.22
€3.30
03.08.23
03.08.23
-12.37%
13.10.22
13.10.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Novavax Inc.
Start price
Target price
Perf. (%)
€34.98
27.08.22
27.08.22
€16.00
27.08.23
27.08.23
-38.94%
13.10.22
13.10.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€72.01
13.10.22
13.10.22
-
-
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€72.01
13.10.22
13.10.22
-
-
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€72.01
13.10.22
13.10.22
-
-
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.10
10.10.21
10.10.21
€15.00
10.10.22
10.10.22
-84.33%
11.10.22
11.10.22
Could be worthwhile Investment >10% per year
Some uniques
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.42
03.10.22
03.10.22
-
03.10.23
03.10.23
-81.66%
07.10.22
07.10.22
Risky Investment